首页> 外文会议>American Peptide Symposium >Synthesis of Analogue of α-MSH for Targeting of Melanocortin Receptors - Copper-Free Click Chemistry Approach
【24h】

Synthesis of Analogue of α-MSH for Targeting of Melanocortin Receptors - Copper-Free Click Chemistry Approach

机译:α-MSH靶向靶向黑素素受体的类似物的合成 - 无铜咔哒化化学方法

获取原文

摘要

Melanoma is a fonii of cancer that starts in melanocytes cells that make pigment melanin. According to the National Cancer Institute, there were 68,130 of new cases of melanoma and 8,650 deaths in the United States in 2010. While melanoma contributes only five percent of all skin cancer, it results in more than fifty percent of deaths related to skin cancer. Also, long-term survival in patients with metastatic disease is only five percent. That is why the early diagnosis of melanoma cancer is critically important for the improvement of survival rate. Melanoma alters expression of cell surface proteins, including adhesion proteins and receptors. For example, melanocortin 1 receptor (MCIR) is one of the five G-protein coupled receptors (MC1R-MC5R) and was found to be overexpressed in more than eighty percent of melanoma tumor samples from patients with metastatic lesions. Thus, MCIR has been investigated as a target for receptor based melanoma diagnosis, as well as monitoring of therapeutic responses, resulting in a discovery of a number of highly potent ligands [1]. For example, [Nle~4, D-Phe~7]- α-MSH labeled with ~(99)mTc-CGCG was shown to bind to melanomas with high avidity. However, this probe also binds to MC3R-MC5Rs, which are found in the kidney and brain. Here, we report the preparation and modification of a peptide ligand that is known to bind selectively to MCIR. We also used an azide-alkyne cycloaddifion reacfion using copper-free click chemistry that can allow us to modify this peptide with a range of different tag-probes for fluorescent and other types of imaging.
机译:黑色素瘤是一种癌症的FONII,从制作颜料黑色素的细胞中开始。据国家癌症研究所称,2010年在美国有68,130例新的黑素瘤和8,650人死亡。虽然黑素瘤仅占所有皮肤癌的5%,它导致超过90%的死亡癌症死亡。此外,转移性疾病患者的长期存活仅为5%。这就是为什么对黑色素瘤癌症的早期诊断对于提高存活率至关重要。黑色素瘤改变细胞表面蛋白的表达,包括粘附蛋白和受体。例如,Melanocortin1受体(MCIR)是5个G-蛋白偶联受体(MC1R-MC5R)中的一种,并且发现从转移性病变患者的Melanoma肿瘤样本中超过百分之八十的黑素瘤肿瘤样品过表达。因此,已经研究了MCIR作为基于受体的黑色素瘤诊断的靶点,以及监测治疗反应,导致许多高效配体的发现[1]。例如,用〜(99)MTC-CGCG标记的[NLE〜4,D-PHE〜7] - α-MSH被显示为具有高亲合力的黑色素瘤。然而,该探针还结合MC3R-MC5RS,其在肾和脑中发现。在此,我们报告了已知肽配体的制备和修饰,该配体可选择地选择性地与mcir结合。我们还使用无铜的咔哒化学用叠氮化物 - 炔烃环形脂肪属,可以让我们用一系列不同的标签探针为荧光和其他类型的成像进行修饰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号